| Caitlin Brianne Halverson, MD | |
|
4637 121st St, Urbandale, IA 50323-2311 | |
| (515) 655-7080 | |
| (515) 655-7090 |
| Full Name | Caitlin Brianne Halverson |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 14 Years |
| Location | 4637 121st St, Urbandale, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548588395 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZD0900X | Pathology - Dermatopathology | MD-42448 (Iowa) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD-42448 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Goldfinch Laboratory Pc | 8123497211 | 4 |
News Archive
Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
University of California regents approved controversial rollbacks in pension and retiree health benefits Monday, including raising the earliest retirement age for future employees to 55, to help plug huge financial gaps in the university's plans (Gordon, 12/14).
"The Lifetime Cost of Current HIV Care in the United States," a major study appearing in the November 2006 issue of Medical Care, projects the cost of treatment for HIV-infected adults using current standards of care.
Poor communication systems at nursing homes can lead to serious injury for residents who are not tended to in a timely manner. A new smartwatch app being developed at Binghamton University could help certified nursing assistants (CNAs) respond to alerts more quickly and help prevent falls.
› Verified 7 days ago
| Entity Name | Regional Laboratory Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891805958 PECOS PAC ID: 6901709062 Enrollment ID: O20040128000391 |
News Archive
Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
University of California regents approved controversial rollbacks in pension and retiree health benefits Monday, including raising the earliest retirement age for future employees to 55, to help plug huge financial gaps in the university's plans (Gordon, 12/14).
"The Lifetime Cost of Current HIV Care in the United States," a major study appearing in the November 2006 issue of Medical Care, projects the cost of treatment for HIV-infected adults using current standards of care.
Poor communication systems at nursing homes can lead to serious injury for residents who are not tended to in a timely manner. A new smartwatch app being developed at Binghamton University could help certified nursing assistants (CNAs) respond to alerts more quickly and help prevent falls.
› Verified 7 days ago
| Entity Name | Broadlawns Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
University of California regents approved controversial rollbacks in pension and retiree health benefits Monday, including raising the earliest retirement age for future employees to 55, to help plug huge financial gaps in the university's plans (Gordon, 12/14).
"The Lifetime Cost of Current HIV Care in the United States," a major study appearing in the November 2006 issue of Medical Care, projects the cost of treatment for HIV-infected adults using current standards of care.
Poor communication systems at nursing homes can lead to serious injury for residents who are not tended to in a timely manner. A new smartwatch app being developed at Binghamton University could help certified nursing assistants (CNAs) respond to alerts more quickly and help prevent falls.
› Verified 7 days ago
| Entity Name | Goldfinch Laboratory Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477277119 PECOS PAC ID: 8123497211 Enrollment ID: O20221212002898 |
News Archive
Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
University of California regents approved controversial rollbacks in pension and retiree health benefits Monday, including raising the earliest retirement age for future employees to 55, to help plug huge financial gaps in the university's plans (Gordon, 12/14).
"The Lifetime Cost of Current HIV Care in the United States," a major study appearing in the November 2006 issue of Medical Care, projects the cost of treatment for HIV-infected adults using current standards of care.
Poor communication systems at nursing homes can lead to serious injury for residents who are not tended to in a timely manner. A new smartwatch app being developed at Binghamton University could help certified nursing assistants (CNAs) respond to alerts more quickly and help prevent falls.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caitlin Brianne Halverson, MD 4637 121st St, Urbandale, IA 50323-2311 Ph: (515) 655-7080 | Caitlin Brianne Halverson, MD 4637 121st St, Urbandale, IA 50323-2311 Ph: (515) 655-7080 |
News Archive
Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
University of California regents approved controversial rollbacks in pension and retiree health benefits Monday, including raising the earliest retirement age for future employees to 55, to help plug huge financial gaps in the university's plans (Gordon, 12/14).
"The Lifetime Cost of Current HIV Care in the United States," a major study appearing in the November 2006 issue of Medical Care, projects the cost of treatment for HIV-infected adults using current standards of care.
Poor communication systems at nursing homes can lead to serious injury for residents who are not tended to in a timely manner. A new smartwatch app being developed at Binghamton University could help certified nursing assistants (CNAs) respond to alerts more quickly and help prevent falls.
› Verified 7 days ago
Jared J Abbott, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4637 121st St, Urbandale, IA 50323 Phone: 515-655-7080 Fax: 515-655-7090 | |
Gregory Alan Schmunk, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2903 160th St, Urbandale, IA 50323 Phone: 515-710-2852 | |
Renee R Ellerbroek, MD Pathology Medicare: Medicare Enrolled Practice Location: 4637 121st St, Urbandale, IA 50323 Phone: 515-655-7080 Fax: 515-655-7090 |